" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

100,000 UK Volunteers Invited to Donate Genome to Science

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
The search for UK volunteers willing to donate their genome and health data to science has begun with the launch today of the Personal Genome Project UK.

PGP-UK, which is directed by Professor Stephan Beck (UCL Cancer Institute), ultimately aims to find 100,000 members of the public willing to take part.

PGP-UK aims to offer every participant analysis of their genome, and every donated genome will potentially enable improvements in personalised medicine. It will be using a novel open consent protocol, enabling genomic data to be linked to medical and health records to create an information-rich resource that is made available under open access, allowing free and unrestricted access.

This means many projects can immediately benefit from PGP-UK data, including the sequencing of 100,000 NHS patients being undertaken by Genomics England to combat diseases such as cancer and other common and rare diseases.

"Donating your genome and health data to science is a great way to enable advances in the understanding of human genetics, biology, and health," said Professor Beck, who has over 30 years experience in genomics and played a leading role in the Human Genome Project.

"This project will establish the practice of open consent in the UK, and enable medical advancement through meeting science’s need for ‘richer’ data. PGP-UK will also engage and educate the UK public on personal genomics and its potential use in medicine.

"Previous work has started the process by giving us vital information on our genes and where and when they are active. Through PGP-UK it will be fascinating to learn how this information translates into the many traits that make us all unique."

Cian Murphy, a PhD Student in Cardiovascular Biomedicine at UCL, has already signed up as a pre-registered volunteer to take part. He said: "Scientists and patients alike suffer from privacy walls. Whether erected for patient security concerns or for less altruistic competitive reasons, they stymy progress and may waste valuable funding repeating independent studies that are perhaps underpowered.

"As the focus of research moves to diseases based on smaller and smaller effects, the research community will need ever more samples. Breaking down these barriers is something I am very eager to support. To that end, I will happily provide my own DNA and medical history. Anonymised or not, I believe the risk in doing so to be minimal and far outweighed by the desired paradigm shift in making this type of data freely available to everyone."

The UK has a strong track record in genomics, most notably as a major contributor to the first sequencing of the human genome by the Human Genome Project in 2000 as part of the international Human Genome Project and the ongoing 1000 Genomes Project. PGP-UK is part of the international Personal Genome Project.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Wednesday, February 03, 2016
UCL Launches £50 million Technology Investment Fund
UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.
Monday, January 25, 2016
DNA ‘Building Blocks’ Pave the Way for Improved Drug Delivery
DNA has been used as a ‘molecular building block’ to construct synthetic bio-inspired pores which will improve the way drugs are delivered and help advance the field of synthetic biology, according to scientists from UCL and Nanion Technologies.
Tuesday, January 19, 2016
First Human Trial for Huntington's Drug
Patients in London are being dosed for the first time with an experimental drug for Huntington’s disease.
Thursday, October 22, 2015
Genes Involved in Schizophrenia and Obesity Highlighted
Genes involved in schizophrenia and obesity have been highlighted in a new UCL study, which could lead to a better understanding of the DNA variants which affect risk of these conditions and aid the development of improved strategies for prevention and treatment.
Monday, October 19, 2015
Possible Evidence for Human Transmission of Alzheimer’s Pathology
Study suggests that under a particular set of circumstances, amyloid-ß may potentially be transmissible through certain medical procedures.
Friday, September 11, 2015
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
Wednesday, July 15, 2015
Smoking Signs
Research reveals epigenetic alterations caused by smoking.
Wednesday, May 20, 2015
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Thursday, February 05, 2015
Autolus Launches With £30m Investment
UCL cancer immunotherapy company, Autolus is launches to develop T-cell therapies for haematological and solid tumours.
Thursday, January 22, 2015
Raman Spectroscopy May Enable Non-Invasive Diagnosis of Bone Diseases
Detection of a genetic ‘brittle bone’ disease known as Osteogenesis Imperfecta (OI) is possible by simply scanning a patient’s limbs.
Wednesday, December 03, 2014
UCL Research Helps Paralyzed Man to Recover Function
UCL scientists develop a pioneering cell transplantation treatment.
Tuesday, October 28, 2014
Light-Activated Antimicrobial Surface Also Works in the Dark
The new antibacterial material, developed by researchers at UCL, has potential for cutting hospital acquired infections.
Tuesday, March 25, 2014
Designer Piercings: New Membrane Pores with DNA Nanotechnology
A new way to build membrane-crossing pores, using Lego-like DNA building blocks, has been developed by scientists.
Tuesday, November 12, 2013
New Director Named for Leading HIV Research Centre in South Africa
Professor Pillay will take up his post on secondment from UCL on 1 November 2013.
Wednesday, September 04, 2013
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Leukemia’s Surroundings Key to its Growth
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
NIH Seeks Research Applications to Study Zika in Pregnancy, Developing Fetus
Institute has announced that the new effort seeks to understand virus effect on reproduction and child development.
Iron in the Blood Could Cause Cell Damage
Concentrations of iron similar to those delivered through standard treatments can trigger DNA damage within 10 minutes, when given to cells in the laboratory.
Neanderthal DNA Influences Human Disease Risk
Large-scale, evolutionary analysis compares genetic data alongside electronic health records.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!